Halozyme Therapeutics Inc... (HALO)

AI Score

Unlock

58.79

-0.03 (-0.05%)

At close: Apr 17, 2025, 3:59 PM

59.00

0.36%

After-hours: Apr 17, 2025, 07:37 PM EDT

Dividends

No dividend history available for Halozyme Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

HALO News

1 week ago · Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market - investors.com
4 weeks ago · Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy? - zacks.com
4 weeks ago · Halozyme Joins the $1 Billion Club - fxempire.com
1 month ago · Halozyme Stock Offers Early Buy Point As Company Hits $1 Billion In Revenue - investors.com
1 month ago · HALO vs. AMGN: Which Stock Is the Better Value Option? - zacks.com
1 month ago · Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock - zacks.com
1 month ago · Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes" - zacks.com
1 month ago · Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock - zacks.com
1 month ago · HALO's Q4 Earnings Beat, Higher Royalties Drive Revenue Growth - zacks.com
2 months ago · Halozyme Therapeutics, Inc. (HALO) Q4 2024 Earnings Call Transcript - seekingalpha.com